There’s always something new and exciting going on at INTERPHEX. Check out our announcements for the very latest news.

Share This:

INTERPHEX 2018 Showcases Innovation in Pharmaceutical, Biotechnology and Device Development and Manufacturing at 39th Annual Conference


NEW YORK, NY; May 2, 2018 – 39th International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization sponsored by Parenteral Drug Association (PDA), attracted over 10,000 global industry professionals and more than 600 forward-thinking exhibitors to discuss the most pressing development and manufacturing challenges of today and tomorrow.

"We are pleased to announce that INTERPHEX continued its longstanding tradition of being THE premier venue where attendees are served comprehensive access to the latest in development, manufacturing technologies and innovation," said Michael Mandl, Group Vice President, INTERPHEX.

"INTERPHEX, supporting more than 160 technology launches and 86 new exhibitors, brought together leaders and suppliers to share knowledge and strategies for managing risk and maximizing efficiency to accelerate commercialization for both drug substance and drug product, “ said Kate Scott, Event Director, INTERPHEX. “The 2018 event was lauded by both attendees and exhibitors as a resounding success."

INTERPHEX 2018 Key Highlights

  • INTERPHEX debuted two new enhancements to this year's conference designed to meet the needs of drug substance industry professionals as well as contract manufacturing (CMO) and contract development and manufacturing services (CDMO).
    • FormulationX featured exhibits, a technical conference and networking focused on drug substance. Sponsored by Elsevier, Dow ChemicalColorcon and Marcor, FormulationX offered attendees an opportunity to meet, procure and share expertise in a dedicated space featuring leading exhibitors and a no-cost technical conference program specific to drug substance.
    • INTERPHEX, with the Pharma and Biopharma Outsourcing Association (PBOA), delivered an expanded dedicated space and targeted conference sessions specifically for CMOs and CDMOs to help realize cost efficiencies and accelerate process and technology innovation.
  • On Day Two, as part of the INTERPHEX Technical Conference, U.S. FDA Deputy Director Lawrence X. Yu, PhD presented to attendees “The Future of Pharmaceutical Quality and the Path to Get There". Dr. Yu shared his expertise and insight on performance-based regulation, Quality by Design, advanced manufacturing technologies, continuous improvement and operational excellence.
  • GE Healthcare Life Sciences showcased some of its newest innovations at INTERPHEX 2018 including the new ÄKTA pilot 600, a bench-top chromatography system that provides the industry with a scalability tool to help intensify process development and simplify transfer to GMP-environments. "INTERPHEX provides a great opportunity to connect with customers and industry leaders to discuss the latest industry trends and technologies," explained David Radspinner, Americas Commercial Leader, BioProcess, GE Healthcare Life Sciences.
  • MG America is a leading supplier of processing and packaging equipment. “INTERPHEX 2018 was a great venue for MG America to showcase our newest processing and packaging equipment," said Fabio Trippodo, President of MG America. "We had strong booth traffic each day and solid leads for a range of machinery.  From case packing and capsule filling to tube filling and inspection technologies, INTERPHEX delivered the audience we needed."
  • demonstrated its pharmaceutical and biotechnology-specific augmented reality solutions. "INTERPHEX is our Super Bowl. Each year, we come here to be a part of the biggest opportunities in pharma. Our Apprentice team had so many exciting conversations at the show this year about the many opportunities for implementing our intelligent technology in the pharma world," said Angelo Stracquatanio, CEO & Co-Founder,
  • Germfree showed off its recently launched bioGO™, a highly flexible platform that provides mobile and modular options for R&D and bioproduction. "Germfree is committed to developing technologies that make a difference in the life sciences," said Kevin Kyle, President, of Germfree.  "INTERPHEX 2018, which served as the perfect venue for Germfree to demonstrate our GMP compliant facilities, provides the intersection of new technologies with industry leaders that can apply them to the next therapeutic breakthroughs."
  • Fluid Air, a division of Spraying Systems Co., is the world leader in spray nozzle technology. "The future of spray dry and microencapsulation was at the INTERPHEX 2018. Our new electrostatic spray dry technology was very well received with companies looking to develop highly volatile drugs that can now be processed at much lower operating temperatures. INTERPHEX gives us the opportunity to network with our customers and meet many new companies," said Joel Migchelbrink, Process Engineer at Fluid Air.

INTERPHEX 2018 Exhibitor Awards
Sponsored by Pharmaceutical Processing, the leading source of pharmaceutical and biopharmaceutical manufacturing news, the INTERPHEX 2018 Exhibitor Awards were presented to suppliers in six categories: Best in Show, Best New Product/Service, Editor’s Choice, Best Technological Innovation, Efficiency Champion, and Biotech Innovation.

  • Best in Show: Vanrx PharmasystemsMicrocell Vial Filler
    A completely robotic aseptic filling machine built within gloveless isolators, creating a highly repeatable filling process for complex drug products. “Winning the Best in Show award at INTERPHEX is an honor for Vanrx. The show brings together the best new ideas in pharmaceutical manufacturing. Our company is excited to be a part of a future where drug products become more personalized and accessible to a greater number of people,” said Greg Speakman, Vice President of Marketing, Vanrx Pharmasystems.
  • Best New Product/Service: Nymi – Nymi Authentication Solution
    The Nymi Authentication Solution features a brand new multi-factor authenticator called the Nymi Band™, a biometrically authenticated wearable that simplifies log attempts across the manufacturing process, from raw material R&D through to finalizing batches to be shipped out to end users.  "Nymi is both honored and excited to win the INTERPHEX Best New Product/Service award for 2018," explained Shawn Chance, VP, Strategy. "Nymi authentication solutions are a relative newcomer to the life sciences industry and the award further validates the value our customers already see in our solution. One of the consistent themes at INTERPHEX this year is the importance of data integrity, and how authentication now plays a more critical role than ever on the shop floor. Nymi offers unique, wearable authentication solutions that address these requirements, raising the data integrity bar to a new level while also reducing friction for the shop floor operator."
  • Editor’s Choice (sponsored by Pharmaceutical Processing): LifeAire SystemsThe LifeAire System
    Its air purification system is ideal for the manufacture of pharmaceutical and biotech intermediates and end products requiring highly-controlled production and testing where sensitivity to ambient air is a factor. "LifeAire is honored to be recognized by INTERPHEX and Pharmaceutical Processing as an innovator of life sciences technology by way of the Editor's Choice Award," said Dr. Kathryn C. Worrilow, Founder and CEO of LifeAire Systems. "It was truly wonderful to connect with attendees at INTERPHEX 2018 and discuss the clinical outcomes associated with our patented, multi-staged, in-duct air purification system that is designed specifically for the critical needs of cleanroom, living cell culture and clinical environments."
  • Biotech Innovation: groninger USAFlexPro50
    This manual or fully loaded automated modular filling and closing system offers maximum process safety in aseptic fill/finish reducing the risk at human intervention. “We’re very pleased to receive the ‘Biotech Innovation Award" from INTERPHEX, which acknowledges an innovative application that addresses industry needs and exceeds previous standards for flexibility, ease of use and economics," said Heiner Dornburg, Managing Director of groninger USA LLC. “Our FlexPro50 standardized modules are ideal for biotech, contract manufacturing and pharmaceutical companies.”

Additional INTERPHEX 2018 Exhibitor Award winners include:

  • MilliporeSigmawas honored with the Best Technologies Innovation Award for its next-generation Millistak+® HC Pro that delivers higher productivity, increased speed, and reduced risk.
  • Steris Life Sciencesreceived the INTERPHEX Efficiency Champion Award for Steris VHP DC-A, a new generation of vaporized hydrogen peroxide decontamination chambers for transfer of materials, components, and material bags into aseptic manufacturing cleanroom areas.

Save the date! INTERPHEX 2019 will be held from April 2-4, 2019 at the Javits Center in New York City. If you would like to be notified when registration is open, please click here.

For the past 39 years, INTERPHEX continues to be, the premier pharmaceutical, biotechnology and device development and manufacturing event where you can “Experience Science through Commercialization." Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,500 global industry professionals and 620+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of no cost technical conference, exhibits, demonstrations, roundtables, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. FormulationX and foundation sponsored by ElsevierDow ChemicalColorcon and Marcor Development launched at the 2018 event to increase the presence on drug substance. INTERPHEX and FormulationX, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on FacebookLinkedInInstagramYouTube and TwitterIPX Blog continues the learning beyond the show floor. For more information, visit

About PDA
The Parenteral Drug Association (PDA) is the leading industry provider of science, technology and regulatory information. PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers education for the community. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical/ biopharmaceutical manufacturing science and regulation so members can better serve patients. For more information about PDA, its members, and its mission, please visit


We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.